Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Yaston Technology Development is a leading Chinese medical artificial intelligence company specializing in the quantitative analysis of medical images. The company utilizes deep learning and advanced computer vision to provide diagnostic support for complex conditions in neurology, oncology, and cardiology. Its core platform, Yasen AI, offers automated tools for the early detection of Alzheimer's disease, epilepsy, and pulmonary nodules. By integrating high-precision analysis into clinical workflows, Yaston aims to standardize medical imaging interpretation and improve diagnostic accuracy. The company's products are widely deployed in top-tier hospitals across China and have received multiple regulatory approvals. Yaston continues to innovate in the field of nuclear medicine and multi-modal imaging to support personalized patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Yaston Technology Development.